We have heard from many stakeholders that the provisions that were put in place have limited FDA's ability.
Michael Burgess: “We have heard from many stakeholders that the provisions that were put in place have limited FDA's ability.”
Editor's note · Context
Burgess discusses concerns about conflict-of-interest provisions affecting FDA expertise.
Share
More from Michael Burgess
I urge adoption of the amendment. It is important, with $31 trillion in national debt, that we be good stewards of taxpayer dollars. The gentleman is right. I have pursued this for a number of years, but it is because it is a noble cause…
I never expected that CMMI was actually going to deliver the cost savings that was promised.
It is now my great privilege and high honor to yield 3 minutes to the gentleman from Texas (Mr. Arrington), the chairman of the Budget Committee, as we debate the first bipartisan budget bill to pass the floor of the House I think in the…
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…





